TG003: Expanding the Frontiers of Clk Kinase Inhibition i...
2025-10-21
Explore the advanced mechanisms and translational potential of TG003, a potent Cdc2-like kinase inhibitor, in alternative splicing modulation and platinum-resistant cancer research. This in-depth analysis reveals novel insights and future directions in Clk-mediated pathway targeting.